199 related articles for article (PubMed ID: 18209879)
1. Adipose tissue expression of 11beta-hydroxysteroid dehydrogenase type 1 in Cushing's syndrome and in obesity.
Espíndola-Antunes D; Kater CE
Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1397-403. PubMed ID: 18209879
[TBL] [Abstract][Full Text] [Related]
2. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
Walker BR
Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766
[TBL] [Abstract][Full Text] [Related]
3. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.
Bujalska IJ; Kumar S; Hewison M; Stewart PM
Endocrinology; 1999 Jul; 140(7):3188-96. PubMed ID: 10385414
[TBL] [Abstract][Full Text] [Related]
5. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
Pereira CD; Azevedo I; Monteiro R; Martins MJ
Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
[TBL] [Abstract][Full Text] [Related]
6. Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
Tomlinson JW; Moore JS; Clark PM; Holder G; Shakespeare L; Stewart PM
J Clin Endocrinol Metab; 2004 Jun; 89(6):2711-6. PubMed ID: 15181046
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific dysregulation of cortisol regeneration by 11βHSD1 in obesity: has it promised too much?
Stomby A; Andrew R; Walker BR; Olsson T
Diabetologia; 2014 Jun; 57(6):1100-10. PubMed ID: 24710966
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome--11beta-hydroxysteroid dehydrogenase type 1.
Stewart PM
Clin Med (Lond); 2005; 5(2):142-6. PubMed ID: 15847006
[No Abstract] [Full Text] [Related]
11. Omental 11beta-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity.
Michailidou Z; Jensen MD; Dumesic DA; Chapman KE; Seckl JR; Walker BR; Morton NM
Obesity (Silver Spring); 2007 May; 15(5):1155-63. PubMed ID: 17495191
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
Seckl JR; Morton NM; Chapman KE; Walker BR
Recent Prog Horm Res; 2004; 59():359-93. PubMed ID: 14749510
[TBL] [Abstract][Full Text] [Related]
13. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
Walker BR; Andrew R
Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
[TBL] [Abstract][Full Text] [Related]
14. Tissue-specific increases in 11beta-hydroxysteroid dehydrogenase type 1 in normal weight postmenopausal women.
Andersson T; Simonyte K; Andrew R; Strand M; Burén J; Walker BR; Mattsson C; Olsson T
PLoS One; 2009 Dec; 4(12):e8475. PubMed ID: 20041117
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.
Stewart PM
Eur J Endocrinol; 2003 Sep; 149(3):163-8. PubMed ID: 12943516
[TBL] [Abstract][Full Text] [Related]
16. Estrogen reduces 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats.
Andersson T; Söderström I; Simonyté K; Olsson T
Obesity (Silver Spring); 2010 Mar; 18(3):470-5. PubMed ID: 19763091
[TBL] [Abstract][Full Text] [Related]
17. Different expression and distribution of 11beta-hydroxysteroid dehydrogenase type 1 in obese and lean animal models of type 2 diabetes.
Czegle I; Margittai E; Senesi S; Benedetti A; Bánhegyi G
Acta Physiol Hung; 2008 Dec; 95(4):419-24. PubMed ID: 19009916
[TBL] [Abstract][Full Text] [Related]
18. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.
Stulnig TM; Waldhäusl W
Diabetologia; 2004 Jan; 47(1):1-11. PubMed ID: 14652720
[TBL] [Abstract][Full Text] [Related]
19. Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease.
Morton NM
Mol Cell Endocrinol; 2010 Mar; 316(2):154-64. PubMed ID: 19804814
[TBL] [Abstract][Full Text] [Related]
20. Endurance exercise training increases adipose tissue glucocorticoid exposure: adaptations that facilitate lipolysis.
Campbell JE; Fediuc S; Hawke TJ; Riddell MC
Metabolism; 2009 May; 58(5):651-60. PubMed ID: 19375588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]